Home/Filings/4/0001181431-03-032036
4//SEC Filing

BILICKI DANIEL S 4

Accession 0001181431-03-032036

CIK 0000883107other

Filed

Nov 19, 7:00 PM ET

Accepted

Nov 20, 3:37 PM ET

Size

14.2 KB

Accession

0001181431-03-032036

Insider Transaction Report

Form 4
Period: 2003-11-18
BILICKI DANIEL S
VP - Sales & Marketing
Transactions
  • Exercise/Conversion

    Common Stock

    2003-11-19$2.38/sh+18,700$44,41318,700 total
  • Sale

    Common Stock

    2003-11-19$5.08/sh18,700$94,9850 total
  • Sale

    Common Stock

    2003-11-18$5.26/sh38,000$199,8690 total
  • Exercise/Conversion

    Common Stock

    2003-11-19$1.75/sh+12,000$21,00012,000 total
  • Exercise/Conversion

    Common Stock

    2003-11-18$1.75/sh+38,000$66,50038,000 total
  • Sale

    Common Stock

    2003-11-19$5.01/sh12,000$60,1500 total
Holdings
  • Stock Option (right to buy)

    Exercise: $3.66From: 2004-03-24Exp: 2013-03-24Common Stock (21,000 underlying)
    21,000
  • Stock Option (right to buy)

    Exercise: $7.69From: 2001-05-24Exp: 2010-05-24Common Stock (50,000 underlying)
    50,000
  • Stock Option (right to buy)

    Exercise: $1.75From: 2000-07-27Exp: 2009-07-27Common Stock (50,000 underlying)
    0
  • Stock Option (right to buy)

    Exercise: $2.38From: 2000-03-15Exp: 2009-03-15Common Stock (50,000 underlying)
    31,300
  • Common Stock

    5,000
  • Stock Option (right to buy)

    Exercise: $10.88From: 2002-01-26Exp: 2011-01-26Common Stock (30,000 underlying)
    30,000
Footnotes (2)
  • [F1]Subject to certain restrictions, beginning on this date, options vest in five equal annual installments.
  • [F2]Subject to certain restrictions, beginning on this date, options vest in three equal annual installments.

Issuer

NANOPHASE TECHNOLOGIES CORPORATION

CIK 0000883107

Entity typeother

Related Parties

1
  • filerCIK 0001185307

Filing Metadata

Form type
4
Filed
Nov 19, 7:00 PM ET
Accepted
Nov 20, 3:37 PM ET
Size
14.2 KB